Addressing Gastrointestinal Motility Disorders: A New Review in Acta Materia Medica

A recent publication in Acta Materia Medica journal brings focus to gastrointestinal motility disorders (GIMDs). These conditions are defined by impaired gastrointestinal motility, and their prevention and treatment present ongoing challenges due to their prevalence and complexity.

Understanding GIMD Pathogenesis

The pathogenesis of GIMDs is multifactorial. Key contributing factors include:

• Dysregulation of the enteric nervous system
• Smooth muscle dysfunction
• Neurotransmitter imbalance
• Chronic inflammation
• Gut microbiota dysbiosis

These elements collectively contribute to the development and progression of GIMDs.

Current Treatment Strategies

Current primary treatments for GIMDs involve modern medicine, utilizing prokinetic agents such as mosapride and domperidone.

Additionally, Traditional Chinese Medicine (TCM) has gained recognition as a complementary and alternative therapy that can offer considerable relief for GIMDs.

This review, based on articles from PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI) databases, provides a comprehensive summary of GIMD pathogenesis and current management strategies.

Future Directions and Precision Medicine

Future research in GIMDs should prioritize the identification of new therapeutic targets and investigate the synergies between TCM and modern medicine.

This strategic approach aims to facilitate a transition from evidence-based medicine to precision medicine, potentially leading to the development of more effective interventions and optimized GIMD management.